Logo Image
|Articles|November 9, 2010

Prestige Ameritech Unveils U.S.-Made N95 Respirator as Flu Season Begins

Prestige Ameritech has received NIOSH and FDA approval to market its new N95 Particulate Filter Respirator and Surgical Mask in time for the 2010 flu season. The new respirator will be sold by Owens & Minor and other distributors. Prestige Ameritech was recently awarded contracts for N95 respirators and surgical masks by the Premier and Med Assets group purchasing organizations.

 

The ProGearTM N95 Respirator has the highest fluid-resistance rating available, a larger-than-normal filter area for easier breathing and speaking, soft stretch-knit headbands for increased comfort, and a convenient dispensing method.

 

Were going to show the healthcare industry that respirators dont have to be bulky, uncomfortable or expensive to be effective, says Dan Reese, president of Prestige Ameritech.

 

Prestige Ameritechs new N95 respirator is another step toward its goal of placing Americas surgical mask and respirator supply back under American control. Much of America's surgical mask and respirator supply is currently imported. Prestige Ameritech is Americas largest domestic manufacturer of surgical masks. Prestige Ameritechs 220,000-square-foot Global Pandemic Preparedness and Response Center is located near Dallas.

Related to this article

View more
A brightly lit Hospital operating room, a surgical team wearing gowns and masks. (Adobe Stock 1790696595 by Damian)
How Can OR Teams Improve Environmental Cleaning Between Surgical Cases?
Turnover pressure can leave critical OR cleaning steps unfinished. Karen deKay, MSN, RN, EBP-C, CNOR, CIC, FAPIC, examines common gaps in environmental hygiene and how shared responsibilities, attention to disinfectant contact time, and ongoing education can help teams strengthen practices between cases.
Read more
Infection preventionists in full PPE with children in DRC. (Image credit: author with AI)
Chasing the Bundibugyo Outbreak: How Static Numbers Hide a Moving Epidemic
Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.
Read more
Health care workers from the US speaking with other health care workers in DRC. (Image credit: author with AI)
What Outbreak Metrics Can and Cannot Tell Us About the Ebola DRC Response
Is the Ebola outbreak in the DRC getting better? The answer depends on which numbers you examine. Several important indicators are moving in the right direction, including slower case growth and a declining Rₜ. But major gaps remain in contact tracing, testing, community deaths, safe burial coverage, and treatment capacity in some of the hardest-hit areas. ICT takes a deeper look at the latest outbreak data and why the numbers suggest cautious optimism, not victory.
Read more